MedPage Today on MSN
Estradiol Patch Matches LHRH Agonists for Locally Advanced Prostate Cancer
Similar 3-year metastasis-free survival, fewer hot flashes, more gynecomastia ...
or on the link below. Androgen-deprivation therapy (ADT) is a cornerstone in the management of prostate cancer. For many years now, luteinizing hormone-releasing hormone (LHRH) agonists have remained ...
Morning Overview on MSN
Trial: Estradiol patches match injections for prostate cancer care
A randomized phase III trial run out of the United Kingdom has found that estradiol skin patches suppress testosterone as ...
Two Sealed Airtight Medical Vials Against Bright Background Front View. Real-world data conflict with a recent meta-analysis including patients from highly selected clinical trial populations.
Differential efficacy of PARP inhibitors in metastatic castration-resistant prostate cancer with DNA repair defects: A systematic review and meta-analysis. This is an ASCO Meeting Abstract from the ...
Credit: Getty Images. Real-world data conflict with a recent meta-analysis including patients from highly selected clinical trial populations. Although a recent meta-analysis suggested that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results